Selective Cytotoxic Mechanism of GTP-14564, a Novel Tyrosine Kinase Inhibitor in Leukemia Cells Expressing a Constitutively Active Fms-like Tyrosine Kinase 3 (FLT3)
Open Access
- 1 August 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (35) , 32892-32898
- https://doi.org/10.1074/jbc.m210405200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesBlood, 2001
- Plat-E: an efficient and stable system for transient packaging of retrovirusesGene Therapy, 2000
- Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cellsBritish Journal of Haematology, 2000
- Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemiaJournal of Clinical Investigation, 2000
- Conditional Activation of Janus Kinase (JAK) Confers Factor Independence upon Interleukin-3-dependent CellsPublished by Elsevier ,1998
- Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-tyrosine KinasePublished by Elsevier ,1996
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populationsCell, 1991
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986
- Reaction of 2-acyl-3-aminobenzofurans with hydrazinesJournal of Heterocyclic Chemistry, 1984